• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

帕金森病认知评定量表(PD-CRS)在哥伦比亚的心理测量特性及结构效度

Psychometric properties and construct validity of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS) in Colombia.

作者信息

Clavijo-Moran Hugo Juan Camilo, Álvarez-García Daniela, Pinilla-Monsalve Gabriel D, Muñoz-Ospina Beatriz, Orozco Jorge

机构信息

Centro de Investigaciones Clínicas, Fundación Valle del Lili, Cali, Colombia.

Departamento de Neurocirugía, Fundación Valle del Lili, Cali, Colombia.

出版信息

Front Psychol. 2022 Dec 1;13:1018176. doi: 10.3389/fpsyg.2022.1018176. eCollection 2022.

DOI:10.3389/fpsyg.2022.1018176
PMID:36533029
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9753700/
Abstract

BACKGROUND

Cognitive impairment is frequent among people living with Parkinson's disease: up to 40% of patients exhibit symptoms of mild cognitive impairment and 25% meet the criteria for dementia. Parkinson's Disease Cognitive Rating Scale (PD-CRS) is one of the recommended scales by the Movement Disorders Society Task Force for level 1 screening of dementia. However, its psychometric properties have not been studied in the Colombian population.

METHODS

A cross-sectional study was conducted on 100 patients with Parkinson's disease diagnosed by a movement disorders neurologist. Patients were evaluated with PD-CRS and MoCA. Principal component analysis was conducted, and then confirmatory factor analysis was implemented through the maximum-likelihood method. Internal consistency was evaluated using Cronbach . Convergent and divergent validity were also calculated and concurrent validity with the MoCA was assessed.

RESULTS

62% were males. Their median age was 68 years (IQR 57-74) and the median disease duration was 4 years (IQR 2-9). 77% were classified in early stages (Hoehn and Yahr stage ≤ 2), while the MDS-UPDRS part III score was 25 (IQR 15.5-38). In the principal component factor analysis, the pattern matrix unveiled a mnesic and a non-mnesic domain. Confirmatory factor analysis showed similar explanatory capacity ( ≥ 0.50) for items other than naming ( = 0.34). Cronbach's for the full 9-items instrument was 0.74. MoCA and PD-CRS total scores were correlated ( = 0.71,  = 0.000). Assuming a cut-off score of 62 points, there is an agreement of 89% with the definition of dementia by MoCA for Colombia ( = 0.59;  = 0.000).

CONCLUSION

PD-CRS has acceptable psychometric properties for the Colombian population and has significant correlation and agreement with a validated scale (MoCA).

摘要

背景

认知障碍在帕金森病患者中很常见:高达40%的患者表现出轻度认知障碍症状,25%符合痴呆症标准。帕金森病认知评定量表(PD-CRS)是运动障碍协会特别工作组推荐的用于痴呆症一级筛查的量表之一。然而,其心理测量特性尚未在哥伦比亚人群中进行研究。

方法

对100名由运动障碍神经科医生诊断为帕金森病的患者进行了一项横断面研究。患者接受了PD-CRS和蒙特利尔认知评估量表(MoCA)评估。进行了主成分分析,然后通过最大似然法实施验证性因子分析。使用克朗巴哈系数评估内部一致性。还计算了聚合效度和区分效度,并评估了与MoCA的同时效度。

结果

62%为男性。他们的年龄中位数为68岁(四分位间距57 - 74),疾病持续时间中位数为4年(四分位间距2 - 9)。77%被归类为早期阶段(霍恩和雅尔分期≤2期),而运动障碍协会统一帕金森病评定量表(MDS-UPDRS)第三部分得分是25分(四分位间距15.5 - 38)。在主成分因子分析中,模式矩阵揭示了一个记忆领域和一个非记忆领域。验证性因子分析显示,除命名项目外(载荷 = 0.34),其他项目具有相似的解释能力(≥0.50)。9项完整量表的克朗巴哈系数为0.74。MoCA和PD-CRS总分具有相关性(r = 0.71,p = 0.000)。假设临界值为62分,与哥伦比亚MoCA对痴呆症的定义一致性为89%(κ = 0.59;p = 0.000)。

结论

PD-CRS对于哥伦比亚人群具有可接受的心理测量特性,并且与一个经过验证的量表(MoCA)具有显著的相关性和一致性。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/815d/9753700/eb83c63afb3f/fpsyg-13-1018176-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/815d/9753700/13a2e02a7a60/fpsyg-13-1018176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/815d/9753700/4b1ddacc0b0e/fpsyg-13-1018176-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/815d/9753700/eb83c63afb3f/fpsyg-13-1018176-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/815d/9753700/13a2e02a7a60/fpsyg-13-1018176-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/815d/9753700/4b1ddacc0b0e/fpsyg-13-1018176-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/815d/9753700/eb83c63afb3f/fpsyg-13-1018176-g003.jpg

相似文献

1
Psychometric properties and construct validity of the Parkinson's Disease-Cognitive Rating Scale (PD-CRS) in Colombia.帕金森病认知评定量表(PD-CRS)在哥伦比亚的心理测量特性及结构效度
Front Psychol. 2022 Dec 1;13:1018176. doi: 10.3389/fpsyg.2022.1018176. eCollection 2022.
2
[Psychometric attributes of the Parkinson's Disease-Cognitive Rating Scale. An independent validation study].[帕金森病认知评定量表的心理测量学属性。一项独立验证研究]
Rev Neurol. 2009;49(8):393-8.
3
Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease.帕金森病认知评定量表在伊朗特发性帕金森病患者中的信度、效度和诊断准确性。
Disabil Rehabil. 2022 May;44(10):2091-2098. doi: 10.1080/09638288.2020.1813337. Epub 2020 Sep 14.
4
Validation of the Parkinson's Disease-Cognitive Rating Scale Applying the Movement Disorder Society Task Force Criteria for Dementia Associated with Parkinson's Disease.应用运动障碍学会帕金森病相关痴呆工作组标准对帕金森病认知评定量表的验证
Mov Disord Clin Pract. 2016 Mar 1;4(1):51-57. doi: 10.1002/mdc3.12338. eCollection 2017 Jan-Feb.
5
Parkinson's Disease-Cognitive Rating Scale for Evaluating Cognitive Impairment in Parkinson's Disease: A Systematic Review.用于评估帕金森病认知障碍的帕金森病认知评定量表:一项系统评价
Brain Sci. 2020 Aug 25;10(9):588. doi: 10.3390/brainsci10090588.
6
Mapping brain morphology to cognitive deficits: a study on PD-CRS scores in Parkinson's disease with mild cognitive impairment.将脑形态与认知缺陷进行映射:一项关于帕金森病伴轻度认知障碍患者帕金森病认知评分量表(PD-CRS)评分的研究
Front Neuroanat. 2024 Aug 14;18:1362165. doi: 10.3389/fnana.2024.1362165. eCollection 2024.
7
Validation of the Italian version of Parkinson's disease-cognitive rating scale (PD-CRS).帕金森病认知评定量表(PD-CRS)意大利版的验证。
Neurol Sci. 2014 Apr;35(4):537-44. doi: 10.1007/s10072-013-1538-y. Epub 2013 Sep 25.
8
Validation of Revised Chinese Version of PD-CRS in Parkinson's Disease Patients.帕金森病患者中帕金森病认知功能评定量表修订中文版的效度验证
Parkinsons Dis. 2020 Feb 19;2020:5289136. doi: 10.1155/2020/5289136. eCollection 2020.
9
Some aspects of the validity of the Montreal Cognitive Assessment (MoCA) for evaluating cognitive impairment in Brazilian patients with Parkinson's disease.蒙特利尔认知评估量表(MoCA)在评估巴西帕金森病患者认知障碍方面的效度的某些方面。
Dement Neuropsychol. 2016 Oct-Dec;10(4):333-338. doi: 10.1590/s1980-5764-2016dn1004013.
10
Clinical features and relative factors of constipation in a cohort of Chinese patients with Parkinson's disease.一组中国帕金森病患者便秘的临床特征及相关因素
World J Gastrointest Pharmacol Ther. 2021 Jan 5;12(1):21-31. doi: 10.4292/wjgpt.v12.i1.21.

引用本文的文献

1
Lewy Body Dementia Research in Latin America: A Scoping Review.拉丁美洲的路易体痴呆症研究:一项范围综述。
Mov Disord Clin Pract. 2025 Apr 21. doi: 10.1002/mdc3.70059.

本文引用的文献

1
Frequency of Non-motor Symptoms in Parkinson's Patients With Motor Fluctuations.帕金森病运动波动患者非运动症状的发生率
Front Neurol. 2021 Jun 29;12:678373. doi: 10.3389/fneur.2021.678373. eCollection 2021.
2
Parkinson disease-associated cognitive impairment.帕金森病相关认知障碍。
Nat Rev Dis Primers. 2021 Jul 1;7(1):47. doi: 10.1038/s41572-021-00280-3.
3
Cognitive Impairment in Parkinson's Disease: Epidemiology, Clinical Profile, Protective and Risk Factors.帕金森病中的认知障碍:流行病学、临床特征、保护因素和风险因素。
Behav Sci (Basel). 2021 May 13;11(5):74. doi: 10.3390/bs11050074.
4
Reliability, validity, and diagnostic accuracy of Parkinson's Disease-Cognitive Rating Scale in Iranian patients with idiopathic Parkinson's disease.帕金森病认知评定量表在伊朗特发性帕金森病患者中的信度、效度和诊断准确性。
Disabil Rehabil. 2022 May;44(10):2091-2098. doi: 10.1080/09638288.2020.1813337. Epub 2020 Sep 14.
5
Parkinson's Disease-Cognitive Rating Scale for Evaluating Cognitive Impairment in Parkinson's Disease: A Systematic Review.用于评估帕金森病认知障碍的帕金森病认知评定量表:一项系统评价
Brain Sci. 2020 Aug 25;10(9):588. doi: 10.3390/brainsci10090588.
6
Validation of Revised Chinese Version of PD-CRS in Parkinson's Disease Patients.帕金森病患者中帕金森病认知功能评定量表修订中文版的效度验证
Parkinsons Dis. 2020 Feb 19;2020:5289136. doi: 10.1155/2020/5289136. eCollection 2020.
7
Prevalence and clinical aspects of mild cognitive impairment in Parkinson's disease: A meta-analysis.帕金森病患者轻度认知障碍的患病率和临床特征:一项荟萃分析。
Mov Disord. 2020 Jan;35(1):45-54. doi: 10.1002/mds.27902. Epub 2019 Nov 19.
8
Impact of non-motor symptoms in Parkinson's disease: a PMDAlliance survey.帕金森病非运动症状的影响:PMD联盟调查
Neuropsychiatr Dis Treat. 2019 Aug 5;15:2205-2212. doi: 10.2147/NDT.S213917. eCollection 2019.
9
Update of the MDS research criteria for prodromal Parkinson's disease.前驱帕金森病 MDS 研究标准的更新。
Mov Disord. 2019 Oct;34(10):1464-1470. doi: 10.1002/mds.27802. Epub 2019 Aug 14.
10
Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study.前驱期帕金森病和路易体痴呆的演变:一项前瞻性研究。
Brain. 2019 Jul 1;142(7):2051-2067. doi: 10.1093/brain/awz111.